BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 19540083)

  • 1. Role of magnetic resonance diffusion-weighted imaging in evaluating response after chemoembolization of hepatocellular carcinoma.
    Yuan Z; Ye XD; Dong S; Xu LC; Xu XY; Liu SY; Xiao XS
    Eur J Radiol; 2010 Jul; 75(1):e9-14. PubMed ID: 19540083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Water mobility of diffusion MRI in prediction of response to chemoembolization in liver cancer].
    Yuan Z; Ye XD; Dong S; Xu LC; Sun ZC; Xiao XS
    Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):293-7. PubMed ID: 19615287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of treatment response of chemoembolization in hepatocellular carcinoma with diffusion-weighted imaging on 3.0-T MR imaging.
    Sahin H; Harman M; Cinar C; Bozkaya H; Parildar M; Elmas N
    J Vasc Interv Radiol; 2012 Feb; 23(2):241-7. PubMed ID: 22019180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of apparent diffusion coefficient to survival for patients with unresectable primary hepatocellular carcinoma after chemoembolization.
    Dong S; Ye XD; Yuan Z; Xu LC; Xiao XS
    Eur J Radiol; 2012 Mar; 81(3):472-7. PubMed ID: 21296517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating local hepatocellular carcinoma recurrence post-transcatheter arterial chemoembolization: is diffusion-weighted MRI reliable as an indicator?
    Goshima S; Kanematsu M; Kondo H; Yokoyama R; Tsuge Y; Shiratori Y; Onozuka M; Moriyama N
    J Magn Reson Imaging; 2008 Apr; 27(4):834-9. PubMed ID: 18383261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma.
    Kamel IR; Bluemke DA; Eng J; Liapi E; Messersmith W; Reyes DK; Geschwind JF
    J Vasc Interv Radiol; 2006 Mar; 17(3):505-12. PubMed ID: 16567675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
    Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
    J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of the effect of transcatheter arterial chemoembolization in treatment of primary hepatocellular carcinoma with magnetic resonance diffusion-weighted imaging: 4-6-week follow-up of 25 cases].
    Fan WJ; Zhang L; Ouyang YS
    Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(35):2474-7. PubMed ID: 19080627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of early imaging response after chemoembolization of hepatocellular carcinoma by phosphorus-31 magnetic resonance spectroscopy-initial experience.
    Yuan Z; Ye XD; Dong S; Xu LC; Xiao XS
    J Vasc Interv Radiol; 2011 Aug; 22(8):1166-73. PubMed ID: 21703872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting response of colorectal hepatic metastasis: value of pretreatment apparent diffusion coefficients.
    Koh DM; Scurr E; Collins D; Kanber B; Norman A; Leach MO; Husband JE
    AJR Am J Roentgenol; 2007 Apr; 188(4):1001-8. PubMed ID: 17377036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of tumor necrosis of hepatocellular carcinoma after chemoembolization: diffusion-weighted and contrast-enhanced MRI with histopathologic correlation of the explanted liver.
    Mannelli L; Kim S; Hajdu CH; Babb JS; Clark TW; Taouli B
    AJR Am J Roentgenol; 2009 Oct; 193(4):1044-52. PubMed ID: 19770328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Added value of diffusion-weighted imaging in the MRI assessment of perilesional tumor recurrence after chemoembolization of hepatocellular carcinomas.
    Yu JS; Kim JH; Chung JJ; Kim KW
    J Magn Reson Imaging; 2009 Jul; 30(1):153-60. PubMed ID: 19557734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial diffusion-weighted MRI in patients with hepatocellular carcinoma: Prediction and assessment of response to transarterial chemoembolization. Preliminary experience.
    Mannelli L; Kim S; Hajdu CH; Babb JS; Taouli B
    Eur J Radiol; 2013 Apr; 82(4):577-82. PubMed ID: 23246330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of diffusion-weighted MRI in distinguishing benign and malignant hepatic lesions.
    Miller FH; Hammond N; Siddiqi AJ; Shroff S; Khatri G; Wang Y; Merrick LB; Nikolaidis P
    J Magn Reson Imaging; 2010 Jul; 32(1):138-47. PubMed ID: 20578020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of diffusion-weighted with T2-weighted Imaging for detection of small hepatocellular carcinoma in cirrhosis: preliminary quantitative study at 3-T.
    Wang H; Wang XY; Jiang XX; Ye ZX
    Acad Radiol; 2010 Feb; 17(2):239-43. PubMed ID: 19962912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison between pathological findings and MR diffusion-weighted imaging in primary hepatocellular carcinoma after transcatheter arterial chemoembolization].
    Xiao YP; Xiao EH; Luo JG; Bian DJ; Li MQ; He Z; Shang QL; Liang B
    Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):914-6. PubMed ID: 19173992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline and Early MR Apparent Diffusion Coefficient Quantification as a Predictor of Response of Unresectable Hepatocellular Carcinoma to Doxorubicin Drug-Eluting Bead Chemoembolization.
    Kokabi N; Ludwig JM; Camacho JC; Xing M; Mittal PK; Kim HS
    J Vasc Interv Radiol; 2015 Dec; 26(12):1777-86. PubMed ID: 26603497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of functional magnetic resonance imaging in assessing metastatic leiomyosarcoma response to chemoembolization.
    Vossen JA; Kamel IR; Buijs M; Liapi E; Georgiades CS; Hong K; Geschwind JF
    J Comput Assist Tomogr; 2008; 32(3):347-52. PubMed ID: 18520535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immediate post-doxorubicin drug-eluting beads chemoembolization Mr Apparent diffusion coefficient quantification predicts response in unresectable hepatocellular carcinoma: A pilot study.
    Kokabi N; Camacho JC; Xing M; Edalat F; Mittal PK; Kim HS
    J Magn Reson Imaging; 2015 Oct; 42(4):981-9. PubMed ID: 25683022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical study of transcatheter arterial chemoembolization plus radiofrequency ablation in hepatocellular carcinoma by magnetic resonance imaging and functional diffusion-weighted imaging].
    Liu YB; Liang CH; Wang QS; Xie SF; Yu YX; Zhang ZL; Liu ZY
    Zhonghua Yi Xue Za Zhi; 2010 Nov; 90(41):2922-6. PubMed ID: 21211398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.